While the new results are promising and access to critical cells that may one day be used in therapy, it is likely to be many years before they can be tested in humans, Zhang says.
Courtesy of you, the entire Kaiser Daily Health Policy Report show, J.earch the archives, or sign up for email delivery at Kaiser Daily Health Policy Report strongly supports imperial network. A free service of The Henry J. Published. Kaiser Family foundatio 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.Director of National Institute General Medical Sciences , part of National Institute of Health . Of the glycan microarray was led The Consortium for Functional Glycomics, an international panel of Scripps scientists from develops and supported by NIGMS. ‘This technology allows researchers An assay hundreds of carbohydrates varieties in one single experiment, ‘mountains said. May ‘offers The glycans microarrays a detailed picture of viral receptor specificity of that are used to that development of new human pathogenic strains, like H5N1 bird flu H5N1 avian influenza can, and could be the the early detection of new viruses causing new epidemics invaluable.
However, the The change from 2-3 to 2-6 receptor specificity of is a major step in the adaptation of avian viruses to a human host and seems to be one of the reasons why the majority of avian viruses including the current avian influenza H5 tribes, not easily from human – to-human the following avian influenza-to-human infections can be transmitted. However, the report indicates that ‘is once established a pillar in new the host types, said virus rear axle may be optimize their specificity to the new host.. Only a newly developed microarray technology – hundreds of by microscopic trial sites on a little interface of the study showed two to six mutations in the conversion binding site preference of avian Antivirus from receptor in the intestine birds perform to the respiratory tract of humans These mutations found , the investigation was already ‘known to increase binding to these receptors are the trial on 16 March 2006 Sci XpressMusic, the pre online version of of Science magazine releases.